Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 1;150(2):e2021055896.
doi: 10.1542/peds.2021-055896.

Emerging Concepts in Congenital Cytomegalovirus

Affiliations
Review

Emerging Concepts in Congenital Cytomegalovirus

Megan H Pesch et al. Pediatrics. .

Abstract

Over a century of research has focused on improving our understanding of congenital cytomegalovirus (cCMV), yet it remains the most common congenital infection in the United States, affecting 3 to 6 per 1000 live born infants each year. Pregnancies affected by cCMV are at a heightened risk of spontaneous abortion and intrauterine fetal demise. Neonates born with cCMV are also at substantial risk for long-term neurodevelopmental sequelae and disability, including sensorineural hearing loss, even those born without clinically apparent disease. Considerable progress has been made in recent years in study of the epidemiology and transmission of cCMV, developing better diagnostic strategies, implementing newborn screening programs, improving therapeutics, and launching vaccine trials. In this article, we review recent developments in the understanding of the virology and immunobiology of cytomegalovirus. We further discuss how this knowledge informs our understanding of the pathophysiology of cCMV and directs strategies aimed at improving outcomes and quality of life for congenitally infected children. We also provide an update on the epidemiology of cCMV in the United States, evolving scientific understanding of maternal-fetal transmission, enhanced screening approaches, and recognition of neonatal and long-term sequelae. Finally, we review the current landscape of pediatric cCMV research and provide recommendations for novel and high-priority areas for future investigation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures (includes financial disclosures): MP serves on the Executive Committee of the National CMV Foundation (unpaid), an advisor to Moderna Therapeutics Inc (unpaid), a consultant for DiaSorin Molecular and Medscape. MRS serves on the scientific advisory committee of the National CMV Foundation none of which had any input into the conceptualization or creation of this manuscript. MRS serves as a paid consultant to Moderna Vaccines.

Figures

Fig. 1.
Fig. 1.
Structure and isomerization of HCMV genome. Representation of the HCMV genome (not on scale) with its four possible isomers (panels ad). In panel a, the orientation of UL and US is based on UL- and US- orientation of the HCMV wild-type reference Merlin (GenBank AY446894). Panels bd correspond to the other three possible isomer orientations. Genome regions that are characteristic for HCMV: IRL, IRS, TRL, TRS, OriLyt repetition (OriLytRep) and a′ are colored in red, purple, gray, green, black and yellow, respectively. Small black arrows correspond to the direction of selected ORFs (UL1, UL145, US1 and US34) which help to illustrate the orientation of the unique regions (big black arrow) between the different isomers. Dashed gray lines connect the specific a′ sequences that contributed to the isomerization.
Figure 2.
Figure 2.
Typical fetal brain development and potential sequelae of congenital cytomegalovirus infection
Fig. 3.
Fig. 3.
CMV virion demonstrating key envelope glycoproteins and glycoprotein complexes important in protective immunity that stand as potential subunit vaccine candidates. Viral envelope, tegument, and nucleocapsid are as indicated. Glycoprotein complexes are labelled; see Table 1 for additional details.

References

    1. Ho M The history of cytomegalovirus and its diseases. Medical microbiology and immunology. 2008;197(2):65–73. - PubMed
    1. Macedo-da-Silva J, Marinho CRF, Palmisano G, Rosa-Fernandes L. Lights and Shadows of TORCH Infection Proteomics. Genes (Basel). 2020;11(8). - PMC - PubMed
    1. Fellah T, Sibiude J, Vauloup-Fellous C, et al. Evolution of awareness and knowledge of congenital cytomegalovirus infection among health care providers in France between 2011 and 2018. J Clin Virol 2020;129:104335. - PubMed
    1. Schleiss MR. Congenital cytomegalovirus: Impact on child health. Contemp Pediatr 2018;35(7):16. - PMC - PubMed
    1. Dollard SC, Dreon M, Hernandez-Alvarado N, et al. Sensitivity of Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus Infection. JAMA Pediatr 2021;3(175):e205441. - PMC - PubMed

Publication types